RBC Capital analyst Arun Viswanathan is keeping his Outperform rating and $120 price target on Albemarle after his investor meetings with the company's management yesterday. The analyst notes that the 12% short interest reflects a market that is skeptical in Albermarle performance amid the spot price decline of lithium in China. However, Viswanathan believes that the stock price decline this year is an "attractive opportunity", with expected decoupling in the realized and spot price expected to yield "strong quarters" and multiple expansion. The analyst also expects Albemarle's other segments to generate cash, offsetting any further potential weakness in Lithium.